Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
06.09.2017 12:50:00

Stocks Under Scanner in the Medical Equipment Space -- Globus Medical, Invacare, ResMed, and Zimmer Biomet

NEW YORK, September 6, 2017 /PRNewswire/ --

If you want a Stock Review on GMED, IVC, RMD, or ZBH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Tuesday, September 05, 2017, the NASDAQ Composite ended the trading session at 6,375.57, down 0.93%; the Dow Jones Industrial Average edged 1.07% lower, to finish at 21,753.31; and the S&P 500 closed at 2,457.85, slightly dropping 0.76%. Losses were broad based as seven out of nine sectors ended the day in negative. This Wednesday, DailyStockTracker.com has initiated reports coverage on the following Medical Appliances & Equipment equities: Globus Medical Inc. (NYSE: GMED), Invacare Corp. (NYSE: IVC), ResMed Inc. (NYSE: RMD), and Zimmer Biomet Holdings Inc. (NYSE: ZBH). Take a look at the free research reports issued today on DailyStockTracker.com for these stocks by signing up at:

http://dailystocktracker.com/register/

Globus Medical 

Audubon, Pennsylvania headquartered Globus Medical Inc.'s stock finished Tuesday's session 0.13% higher at $30.36 with a total trading volume of 528,607 shares. The Company's shares have advanced 26.66% over the past twelve months and 22.37% since the start of this year. The stock is trading above its 200-day moving average by 5.74%. Additionally, shares of Globus Medical, which focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders, have a Relative Strength Index (RSI) of 52.87. Sign up and read the free research report on GMED at:

http://dailystocktracker.com/registration/?symbol=GMED

Invacare 

On Tuesday, shares in Elyria, Ohio headquartered Invacare Corp. recorded a trading volume of 293,773 shares. The stock ended the session 0.36% lower at $13.70. The Company's shares have advanced 11.84% over the last twelve months. The stock is trading above its 200-day moving average by 6.78%. Moreover, shares of Invacare, which together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide, have an RSI of 51.32. The complimentary research report on IVC can be downloaded at:

http://dailystocktracker.com/registration/?symbol=IVC

ResMed 

San Diego, California headquartered ResMed Inc.'s shares closed the day 1.28% lower at $76.60. The stock recorded a trading volume of 850,170 shares. The Company's shares have gained 14.23% over the last twelve months and 23.45% since the start of the year. The stock is trading above its 50-day and 200-day moving averages by 0.95% and 9.38%, respectively. Additionally, shares of ResMed, which develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases, have an RSI of 57.92. Register for free on DailyStockTracker.com and access the latest report on RMD at:

http://dailystocktracker.com/registration/?symbol=RMD

Zimmer Biomet Holdings 

Shares in Warsaw, Indiana headquartered Zimmer Biomet Holdings Inc. finished 0.08% lower at $114.24. The stock recorded a trading volume of 1.50 million shares, which was above its three months average of 1.41 million shares. The Company's shares have advanced 10.70% on an YTD basis. The stock is trading below its 50-day moving average by 5.86%. Furthermore, shares of Zimmer Biomet, which together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, Middle-East, Africa, and Asia/Pacific, have an RSI of 43.94.

On August 24th, 2017, research firm Gabelli & Co initiated a 'Buy' rating on the Company's stock, with a target price of $142 per share. Get free access to your research report on ZBH at:

http://dailystocktracker.com/registration/?symbol=ZBH

Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@dailystocktracker.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://dailystocktracker.com/disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: contact@dailystocktracker.com
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE dailystocktracker.com

Analysen zu Globus Medical Inc (A)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Globus Medical Inc (A) 81,00 0,62% Globus Medical Inc (A)
Invacare Corp. 0,37 -1,28% Invacare Corp.
ResMed Inc. 228,50 0,13% ResMed Inc.
Zimmer Biomet 105,30 1,99% Zimmer Biomet